این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
International Journal of Hematology-Oncology and Stem Cell Research، جلد ۱۷، شماره ۱، صفحات ۴-۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Frequency of Kell and Rh Alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran
چکیده انگلیسی مقاله Background:  Thalassemia is an inherited disease with anemia and hemolysis. Blood transfusion is a routine treatment for thalassemia patients; alloimmunization is one of the complications of blood transfusion, which is very serious for these patients, especially girls and young women.    Materials and Methods:  Four hundred forty-six thalassemia patients were examined in this cross-sectional study. Demographic information of patients was extracted and recorded. The phenotype of ABO, Rh, and Kell antigens (tube method) with antisera from IMMUNDIANOSTICA Company (Germany) and the frequency of alloantibodies were determined. Results: 55.8% of the studied individuals were male and 44.2% were female. The mean age of the studied patients was 19.94±10.63.  The alloantibodies were detected in 7.5% of pack cell receivers. The most prevalent phenotype of the ABO system was the O blood group (37.4%), and the most abundant antigen of the Rh group was ‘e’, which was found in 99.8% of the studied population. The most frequently detected alloantibody was Anti K (38.2%); concerning kell phenotype, (K_k+) and (K+k+) were found in 99.3% and 0.7% of patients, respectively. The frequency of Anti-D, Anti-C, Anti-c, and Anti-E was 23.5%, 14.7%, 2.9%, and 14.7%, respectively. Conclusion: According to the results of this paper, finding the compatible pack cells in terms of Kell and Rh systems antigens in addition to the ABO blood group is recommended to decrease the rate of alloantibodies in thalassemia patients.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Farzad Mollahoseini Foomani
Blood Transfusion Organization Research Center, Iranian Blood Transfusion Organization, Mashhad, Iran


| Mahammad Hadi Sadeghain
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran


| Saeede Bagheri
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran


| Zahra Badiee
4Pediatrics Department, Doctor Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran


| Reihane Bazargani
Blood Transfusion Organization Research Center, Iranian Blood Transfusion Organization, Mashhad, Iran


| Zahra Aryanpour
Blood Transfusion Organization Research Center, Iranian Blood Transfusion Organization, Mashhad, Iran


| Saeid Hallajian
Blood Transfusion Organization Research Center, Iranian Blood Transfusion Organization, Mashhad, Iran


| Seyyede Fatemeh Shams
Blood Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
نشانی اینترنتی https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1453
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات